Paul Frankenbach/LinkedIn
Sep 2, 2026, 17:22
Paul Frankenbach: New Insights into the Signaling Pathways of Antiphospholipid Antibodies at ISTH 2026
Paul Frankenbach, PhD Candidate at University Medical Center Mainz, shared a post on LinkedIn:
”I had the opportunity to present my research on the critical signaling pathways of different antiphospholipid antibodies at the International Society on Thrombosis and Haemostasis (ISTH) in Paris.
I am very grateful for the support from my supervisors Nadine Müller-Calleja and Wolfram Ruf, my co-authors and the DFG!
It was wonderful to connect with so many experts, exchange ideas, find new friends, and receive valuable feedback on my work.
Looking forward to continuing these discussions in the coming years!”
Stay updated with Hemostasis Today.
-
Sep 2, 2026, 17:21Ahmed Mahmoud: Triple Versus Double Antithrombotic Therapy After PCI in Atrial Arrhythmia
-
Sep 2, 2026, 17:18Assumpta Chiamaka Osumune: Research Meets Community Care in the Fight Against Malaria and Anemia
-
Sep 2, 2026, 17:14Trisha Mallick: Happy to Share Our New Publication on Anemia Among Female University Students
-
Sep 2, 2026, 17:11Joanne de Vries: Sanofi Opens Senior Leadership Opportunity in Rare Blood Disorders
-
Sep 2, 2026, 17:09Muhammad Shahid: New Publication on a Multifunctional Hydrogel for Enhanced Hemostasis
-
Sep 2, 2026, 17:07Are Infants With Haemophilia Getting Enough Opportunities to Move, Explore, and Develop? – EAHAD
-
Sep 2, 2026, 17:05Rucha Patil: Improving Patient Access and Care for Haemophilia in Uttar Pradesh
-
Sep 2, 2026, 15:41Nour Al-Mozain: Rethinking the Role of Cold-Stored Platelets
-
Sep 2, 2026, 15:39Fahad Alshehri: Are All Platelets Created Equal?